DOCSLIB.ORG

DNA REPAIR Genomic Maintenance and Responses to DNA Damage

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DNA REPAIR Genomic Maintenance and Responses to DNA Damage DNA REPAIR Genomic maintenance and responses to DNA damage AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.9 ISSN: 1568-7864 DESCRIPTION . DNA Repair provides a forum for the comprehensive coverage of DNA repair and cellular responses to DNA damage. The journal publishes original observations on genetic, cellular, biochemical, structural and molecular aspects of DNA repair, mutagenesis, cell cycle regulation, apoptosis and other biological responses in cells exposed to genomic insult, as well as their relationship to human disease. DNA Repair publishes full-length research articles, brief reports on research, and reviews. The journal welcomes articles describing databases, methods and new technologies supporting research on DNA repair and responses to DNA damage. Letters to the Editor, hot topics and classics in DNA repair, historical reflections, book reviews and meeting reports also will be considered for publication. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center IMPACT FACTOR . 2020: 4.913 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/dnarepair 1 ABSTRACTING AND INDEXING . Scopus PubMed/Medline EMBiology BIOSIS Citation Index Biological Abstracts Chemical Abstracts Elsevier BIOBASE Current Contents - Life Sciences Embase Pascal Francis Reference Update Web of Science EDITORIAL BOARD . Co-Editors-in-Chief Penny A. Jeggo, University of Sussex,Genome Damage and Stability Centre,University of Sussex, Brighton, United Kingdom DNA damage response to DNA double strand breaks Bennett Van Houten, UPMC Hillman Cancer Center Shadyside, Pittsburgh, Pennsylvania, United States of America DNA Repair, drug discovery, redox pharmacology, pharmacology of cell and organ systems Editors Emeritus Errol C. Friedberg P.C. Hanawalt S.H. Wilson Associate Editors Keith W. Caldecott, University of Sussex, Brighton, United Kingdom Ageing, drug discovery, mitosis, neurodegeneration, proteomics Jessica A. Downs, The Institute of Cancer Research, London, United Kingdom Epigenetics and genome stability Sue Jinks-Robertson, Duke University, Durham, North Carolina, United States of America Mechanisms of homologous recombination, transcription and genome stability Alan R. Lehmann, University of Sussex, Brighton, United Kingdom Xeroderma pigmentosum, Cockayne Syndrome, trichothiodystrophy Guo-Min Li, The University of Texas Southwestern Medical Center Department of Radiation Oncology, Dallas, Texas, United States of America DNA mismatch repair, genome instability, cancer, DNA Damage response, epigenetics, histone modifications and mutations, post-translational modifications Jeffrey H. Miller, University of California Los Angeles, Los Angeles, California, United States of America Mutation, DNA repair Marco Muzi Falconi, University of Milan Department of Biomolecular Sciences at Biotechnology, Milan, Milan, Italy Genome integrity, DNA damage checkpoints, initiation of DNA replication Rodney Rothstein, Columbia University Department of Genetics and Development, New York, New York, United States of America Genome stability Leona D. Samson, Massachusetts Institute of Technology Center for Environmental Health Sciences, Cambridge, Massachusetts, United States of America Toxigenomics, animal models of DNA repair, DNA repair pathways, Genomic phenotyping, spontaneous mutagenesis, gene environment interactions, structure function relationship Robert W. Sobol, University of South Alabama, Mitchell Cancer Institute, Molecular and Metabolic Oncology Program, Mobile, Alabama, United States of America DNA Repair, base excision repair, DNA damage response, ADP-ribose, Poly-ADP-ribose polymerase, DNA polymerases, NAD+ metabolism Shunichi Takeda, Kyoto University Graduate School of Medicine Faculty of Medicine Department of Radiation Genetics, Kyoto, Japan Reverse genetics, radiation genetics AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/dnarepair 2 Alan Tomkinson, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America Protein-nucleic acid interaction, DNA recombination, genomic instability, DNA enzyme, nucleotide excision repair, base excision repair (BER), protein-protein interaction, DNA mismatch repair, DNA damage response, zinc finger, DNA-protein interaction, DNA damage, DNA replication, radiation biology, DNA repair, nucleic acid enzymology, reactive oxygen species (ROS) Niels de Wind, Leiden University Medical Centre Center for Human and Clinical Genetics, Leiden, Netherlands DNA damage responses, mutagenesis, DNA translesion synthesis, DNA mismatch repair Roger Woodgate, National Institutes of Health, Bethesda, Maryland, United States of America DNA replication, repair, and mutagenesis in eukaryotic and prokaryotic cells Editorial Board Haico van Attikum, Leiden University Medical Centre Center for Human and Clinical Genetics, Leiden, Netherlands Chromatin and DNA repair, systems biiology, ubiquitination, chromatin-modifying factors Christopher J. Bakkenist, Hillman Cancer Center,Sch. of Medicine; Dept. of Radiation Oncology,University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America Cancer pharmacology, DNA repair, radiation oncology, chemical biology Thomas J. Begley, University at Albany College of Nanoscale Science and Engineering, Albany, New York, United States of America DNA repair, genetic toxicology, environmental health, epitranscriptomics, tRNA modifications and translation Kara A. Bernstein, University of Pittsburgh Department of Microbiology and Molecular Genetics, Pittsburgh, Pennsylvania, United States of America double-strand break repair, homologous recombination, RAD51 regulation Ashok S. Bhagwat, Wayne State University Department of Chemistry, Detroit, Michigan, United States of America Functional genomics Sukesh R. Bhaumik, Southern Illinois University School of Medicine Department of Biochemistry and Molecular Biology, Carbondale, Illinois, United States of America Keywords: Transcription, Chromatin Structure, DNA Repair, and Genomic Instability Margherita Bignami, National Institute of Health Department of Environment Health and Health, Roma, Italy Luis Blanco, Autonomous University of Madrid Campus Spanish Research Council Severo Ochoa Molecular Biology Centre, Madrid, Spain Genome maintenance and variability, enzymology of DNA replication and repair Linda B. Bloom, University of Florida Department of Biochemistry and Molecular Biology, Gainesville, Florida, United States of America DNA replication and repair Daniel F. Bogenhagen, Stony Brook University Department of Pharmacological Sciences, Stony Brook, New York, United States of America Mitochondrial DNA (mtDNA) replication, transcription and repair in animal cells Vilhelm Bohr, Biomedical Research Center,Lab. of Molecular Gerontology,National Institute of Aging (NIA), Baltimore, Maryland, United States of America DNA repair, telomere maintenance, base excision DNA repair, helicase function, aging, neurodegeneration Serge Boiteux, French Alternative Energies and Atomic Energy Commission Laboratory of Genetic and Molecular Radiobiology, Fontenay aux Roses, France William M. Bonner, , MD, United States of America Chromosome biology Anne Bagg Britt, Life Sciences Addition, room 1002,Dept. of Plant Biology,University of California, Davis, Davis, California, United States of America Cell and developmental biology, chromosome biology, environmental and Integrative biology, model plants, molecular biology, biochemistry and genomics Jaap Brouwer, Leiden Inst. of Chemistry (Scheikunde Universiteit Leiden),Molecular Genetics,Universiteit Leiden, Leiden, Netherlands Molecular genetics Sandeep Burma, Div. of Molecular Radiation Biology,Dept. of Radiation Oncology,University of Texas Southwestern Medical Center, Dallas, Texas, United States of America DNA recombination, glioblastoma, DNA-dependent serine/threonine protein kinase (DNA-PK), ataxia telangiectasia, cancer therapy, DNA damage response, cyclin-dependent kinase (CDK), DNA damage, cellular senescence, cell cycle, cancer, BRCA1, BRCA2, DNA repair, brain tumor Tony Carr, University of Sussex, Brighton, United Kingdom Genome stability AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/dnarepair 3 David J. Chen, Div. of Molecular Radiation Biology,Dept. of Radiation Oncology,University of Texas Southwestern Medical Center, Dallas, Texas, United States of America DNA repair and nuclear organization Dipanjan Chowdhury, Harvard Medical School, Boston, MA, United States of America DNA double strand break repair, phosphatase, non-coding RNA Andrew R. Collins, Fac. of Medicine,Dept. of Nutrition,University of Oslo, Oslo, Norway Comet Assay, DNA damage and mutagenesis, nutrition and cancer, DNA repair in mammalian cells, human biomonitoring; molecular epidemiology Priscilla K. Cooper, E O Lawrence Berkeley National Laboratory, Berkeley, California, United States of America Richard P. Cunningham, University at Albany Department of Biological Sciences, Albany, New York, United States of America Biochemistry of DNA repair enzymes, DNA repair in bacteria, structure
Load more

Recommended publications
  • 1 INTRODUCTION DNA Damage and Types of Repair DNA Is Subject to Various Types of Damage That Can Impair Cellular Function Leadin
    INTRODUCTION DNA damage and types of repair DNA is subject to various types of damage that can impair cellular function leading to cell death or carcinogenesis. DNA damage blocks normal cellular processes such as replication and transcription [1, 2]. Should DNA damage persist it can have catastrophic consequences for the cell and for the organism including mutagenesis, cancer, and cell death (i.e. in neurons). DNA damage may come from internal as well as external sources and is associated with various types of genetic diseases and cancers. Therefore DNA repair provides a mechanism to restore DNA nucleotide sequences to the native state. Several DNA repair pathways have been identified including base excision repair (BER), mismatch repair (MMR) and nucleotide excision repair (NER). The type of lesion will dictate which pathway is utilized for repair. For example an N7-methyl guanine residue can only be removed by BER, while a benzopyrene guanine adduct residue can only be removed by NER [3]. Nucleotide Excision Repair Nucleotide Excision Repair (NER) is a versatile DNA repair pathway because of its ability to repair a wide range of nucleotide adducts [4]. NER is responsible for the repair of bulky DNA damage lesions including cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine pyrimidone photoproducts (6-4PPs) caused by UV radiation [3, 5]. NER repairs platinum DNA adducts that are formed by cancer chemotherapeutic drugs such as cisplatin and carboplatin [1, 6, 7]. UV radiation and platinum compounds cause covalent linkage of adjacent thymine or guanine residues respectively. Aromatic 1 hydrocarbons, as found in cigarette smoke, cause guanine adducts that also require NER for their removal.
    [Show full text]
  • DNA Damage Induced During Mitosis Undergoes DNA Repair
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.03.893784; this version posted January 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 DNA damage induced during mitosis 2 undergoes DNA repair synthesis 3 4 5 Veronica Gomez Godinez1 ,Sami Kabbara2,3,1a, Adria Sherman1,3, Tao Wu3,4, 6 Shirli Cohen1, Xiangduo Kong5, Jose Luis Maravillas-Montero6,1b, Zhixia Shi1, 7 Daryl Preece,4,3, Kyoko Yokomori5, Michael W. Berns1,2,3,4* 8 9 1Institute of Engineering in Medicine, University of Ca-San Diego, San Diego, California, United 10 States of America 11 12 2Department of Developmental and Cell Biology, University of Ca-Irvine, Irvine, California, United 13 States of America 14 15 3Beckman Laser Institute, University of Ca-Irvine, Irvine, California, United States of America 16 17 4Department of Biomedical Engineering, University of Ca-Irvine, Irvine, California, United States of 18 America 19 20 5Department of Biological Chemistry, University of Ca-Irvine, Irvine, California, United States of 21 America 22 23 6Department of Physiology, University of Ca-Irvine, Irvine, California, United States of America 24 25 1aCurrent Address: Tulane Department of Opthalmology, New Orleans, Louisiana, United States of 26 America 27 28 1bCurrent Address: Universidad Nacional Autonoma de Mexico, Mexico CDMX, Mexico 29 30 31 32 *Corresponding Author 33 34 [email protected](M.W.B) 35 36 37 38 39 40 41 42 43 44 45 46 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.03.893784; this version posted January 3, 2020.
    [Show full text]
  • Molecular Anatomy and Regulation of a Stable Replisome at a Paused Eukaryotic DNA Replication Fork
    Downloaded from genesdev.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Molecular anatomy and regulation of a stable replisome at a paused eukaryotic DNA replication fork Arturo Calzada,1,2,3 Ben Hodgson,1,3 Masato Kanemaki,1 Avelino Bueno,2 and Karim Labib1,4 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, United Kingdom; 2Cancer Research Institute, University of Salamanca/CSIC, 37007 Salamanca, Spain Eukaryotic cells regulate the progression and integrity of DNA replication forks to maintain genomic stability and couple DNA synthesis to other processes. The budding yeast proteins Mrc1 and Tof1 associate with the putative MCM–Cdc45 helicase and limit progression of the replisome when nucleotides are depleted, and the checkpoint kinases Mec1 and Rad53 stabilize such stalled forks and prevent disassembly of the replisome. Forks also pause transiently during unperturbed chromosome replication, at sites where nonnucleosomal proteins bind DNA tightly. We describe a method for inducing prolonged pausing of forks at protein barriers assembled at unique sites on a yeast chromosome, allowing us to examine for the first time the effects of pausing upon replisome integrity. We show that paused forks maintain an intact replisome that contains Mrc1, Tof1, MCM–Cdc45, GINS, and DNA polymerases ␣ and ␧ and that recruits the Rrm3 helicase. Surprisingly, pausing does not require Mrc1, although Tof1 and Csm3 are both important. In addition, the integrity of the paused forks does not require Mec1, Rad53, or recombination. We also show that paused forks at analogous barriers in the rDNA are regulated similarly. These data indicate that paused and stalled eukaryotic replisomes resemble each other but are regulated differently.
    [Show full text]
  • Incision of Damaged DNA in the Presence of an Impaired Smc5/6 Complex Imperils Genome Stability Jie Peng and Wenyi Feng*
    10216–10229 Nucleic Acids Research, 2016, Vol. 44, No. 21 Published online 17 August 2016 doi: 10.1093/nar/gkw720 Incision of damaged DNA in the presence of an impaired Smc5/6 complex imperils genome stability Jie Peng and Wenyi Feng* Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA Received February 01, 2016; Revised August 05, 2016; Accepted August 08, 2016 ABSTRACT cleotide excision repair (RER) pathways, respectively (7). / Virtually all DNA repair pathways require recognition and The Smc5 6 complex is implicated in homologous subsequent excisions of the damaged nucleotide, giving rise recombination-mediated DNA repair during DNA to a single-stranded gap in the DNA polymer (7). The mech- damage or replication stress. Here, we analysed anisms ensuring such a structural alteration of the chro- genome-wide replication dynamics in a hypomorphic mosome is efficiently repaired and does not lead to further budding yeast mutant, smc6-P4. The overall replica- degradation are underexplored. Conceivably, these mecha- tion dynamics in the smc6 mutant is similar to that nisms would involve protein complexes directly interacting in the wild-type cells. However, we captured a dif- with the chromosomal DNA and implicated in DNA dam- ference in the replication profile of an early S phase age or replication stress response. sample in the mutant, prompting the hypothesis that One of the three evolutionarily conserved Structure the mutant incorporates ribonucleotides and/or ac- Maintenance of Chromosome (SMC) protein complexes, the Smc5/6 complex, plays a key role in DNA damage re- cumulates single-stranded DNA gaps during replica- pair.
    [Show full text]
  • Working on Genomic Stability: from the S-Phase to Mitosis
    G C A T T A C G G C A T genes Review Working on Genomic Stability: From the S-Phase to Mitosis Sara Ovejero 1,2,3,* , Avelino Bueno 1,4 and María P. Sacristán 1,4,* 1 Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Universidad de Salamanca-CSIC, Campus Miguel de Unamuno, 37007 Salamanca, Spain; [email protected] 2 Institute of Human Genetics, CNRS, University of Montpellier, 34000 Montpellier, France 3 Department of Biological Hematology, CHU Montpellier, 34295 Montpellier, France 4 Departamento de Microbiología y Genética, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain * Correspondence: [email protected] (S.O.); [email protected] (M.P.S.); Tel.: +34-923-294808 (M.P.S.) Received: 31 January 2020; Accepted: 18 February 2020; Published: 20 February 2020 Abstract: Fidelity in chromosome duplication and segregation is indispensable for maintaining genomic stability and the perpetuation of life. Challenges to genome integrity jeopardize cell survival and are at the root of different types of pathologies, such as cancer. The following three main sources of genomic instability exist: DNA damage, replicative stress, and chromosome segregation defects. In response to these challenges, eukaryotic cells have evolved control mechanisms, also known as checkpoint systems, which sense under-replicated or damaged DNA and activate specialized DNA repair machineries. Cells make use of these checkpoints throughout interphase to shield genome integrity before mitosis. Later on, when the cells enter into mitosis, the spindle assembly checkpoint (SAC) is activated and remains active until the chromosomes are properly attached to the spindle apparatus to ensure an equal segregation among daughter cells.
    [Show full text]
  • S41467-017-00634-0.Pdf
    ARTICLE DOI: 10.1038/s41467-017-00634-0 OPEN BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination Weiran Feng 1,2 & Maria Jasin1,2 Mutations in the tumor suppressor BRCA2 predominantly predispose to breast cancer. Paradoxically, while loss of BRCA2 promotes tumor formation, it also causes cell lethality, although how lethality is triggered is unclear. Here, we generate BRCA2 conditional non- transformed human mammary epithelial cell lines using CRISPR-Cas9. Cells are inviable upon BRCA2 loss, which leads to replication stress associated with under replication, causing mitotic abnormalities, 53BP1 nuclear body formation in the ensuing G1 phase, and G1 arrest. Unexpected from other systems, the role of BRCA2 in homologous recombination, but not in stalled replication fork protection, is primarily associated with supporting human mammary epithelial cell viability, and, moreover, preventing replication stress, a hallmark of pre- cancerous lesions. Thus, we uncover a DNA under replication-53BP1 nuclear body formation- G1 arrest axis as an unanticipated outcome of homologous recombination deficiency, which triggers cell lethality and, we propose, serves as a barrier that must be overcome for tumor formation. 1 Developmental Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. 2 Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Correspondence and requests for materials should be addressed to M.J. (email: [email protected]) NATURE COMMUNICATIONS | 8: 525 | DOI: 10.1038/s41467-017-00634-0 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00634-0 onoallelic inheritance of a deleterious mutation in Results the BRCA1 or BRCA2 tumor suppressor confers BRCA2 is essential for human mammary MCF10A cell viability.
    [Show full text]
  • Insight Into the DNA Repair Mechanism Operating During Cell Cycle Checkpoints in Eukaryotic Cells Biology and Medicine
    eISSN: 09748369 Insight into the DNA repair mechanism operating during cell cycle checkpoints in eukaryotic cells Biology and Medicine Review Article Volume 4, Issue 4, Pages 147-166, 2012 Review Article Biology and Medicine, 4 (4): 147-166, 2012 www.biolmedonline.com Insight into the DNA repair mechanism operating during cell cycle checkpoints in eukaryotic cells M Asimuddin, K Jamil* Centre for Biotechnology and Bioinformatics, School of Life Sciences, Jawaharlal Nehru Institute of Advance Studies, Buddha Bhavan, MG Road, Secunderabad, Andhra Pradesh, India. *Corresponding Author: [email protected] Accepted: 11th Sep 2012, Published: 28th Sep 2012 Abstract In this article, we have briefly reviewed the molecular mechanism involved in DNA damage and repair at various checkpoints of the cell cycle in eukaryotic cells. Eukaryotic cells have an ability to develop a response to DNA damage that can be caused by environmental factors such as chemicals, xenobiotics, free radicals, ionizing radiation (IR) or products of intracellular metabolism and also due to products of medical therapy. In response to these insults, the following reactions can take place in the cellular environment: (a) In the case of DNA damage, the protein machinery is activated and attaches itself to the site of the lesion which results in cell cycle arrest at the G1 to S phase (the G1/S checkpoint), DNA replication phase (the intra-S checkpoint), or G2 to mitosis phase (the G2/M checkpoint) until the lesion undergoes repair; (b) As there are many different lesions possible, the following DNA repair mechanisms are activated which include direct repair, base excision repair, nucleotide excision repair, mismatch repair, and double strand breaks (DSBs) such as, homologous recombination (HR) and non-homologous end-joining (NHEJ) repair.
    [Show full text]
  • Exploiting DNA Replication Stress for Cancer Treatment Tajinder Ubhi1,2 and Grant W
    Published OnlineFirst April 9, 2019; DOI: 10.1158/0008-5472.CAN-18-3631 Cancer Review Research Exploiting DNA Replication Stress for Cancer Treatment Tajinder Ubhi1,2 and Grant W. Brown1,2 Abstract Complete and accurate DNA replication is fundamental to associated with such therapies. We discuss how replication cellular proliferation and genome stability. Obstacles that stress modulates the cell-intrinsic innate immune response delay, prevent, or terminate DNA replication cause the phe- and highlight the integration of replication stress with immu- nomena termed DNA replication stress. Cancer cells exhibit notherapies. Together, exploiting replication stress for cancer chronic replication stress due to the loss of proteins that treatment seems to be a promising strategy as it provides a protect or repair stressed replication forks and due to the selective means of eliminating tumors, and with continuous continuous proliferative signaling, providing an exploitable advances in our knowledge of the replication stress response therapeutic vulnerability in tumors. Here, we outline current and lessons learned from current therapies in use, we are and pending therapeutic approaches leveraging tumor-specific moving toward honing the potential of targeting replication replication stress as a target, in addition to the challenges stress in the clinic. Introduction mental. In this review, we provide a summary of the therapies centered on enhancing both endogenous and drug-induced rep- The DNA replication machinery successfully carries out accu- lication stress and discuss the rationales associated with them. We rate genome duplication in the face of numerous obstacles, many also highlight the potential of using replication stress to stimulate of which cause DNA replication stress.
    [Show full text]
  • Exploiting DNA Replication Stress for Cancer Treatment Tajinder Ubhi1,2 and Grant W
    Published OnlineFirst April 9, 2019; DOI: 10.1158/0008-5472.CAN-18-3631 Cancer Review Research Exploiting DNA Replication Stress for Cancer Treatment Tajinder Ubhi1,2 and Grant W. Brown1,2 Abstract Complete and accurate DNA replication is fundamental to associated with such therapies. We discuss how replication cellular proliferation and genome stability. Obstacles that stress modulates the cell-intrinsic innate immune response delay, prevent, or terminate DNA replication cause the phe- and highlight the integration of replication stress with immu- nomena termed DNA replication stress. Cancer cells exhibit notherapies. Together, exploiting replication stress for cancer chronic replication stress due to the loss of proteins that treatment seems to be a promising strategy as it provides a protect or repair stressed replication forks and due to the selective means of eliminating tumors, and with continuous continuous proliferative signaling, providing an exploitable advances in our knowledge of the replication stress response therapeutic vulnerability in tumors. Here, we outline current and lessons learned from current therapies in use, we are and pending therapeutic approaches leveraging tumor-specific moving toward honing the potential of targeting replication replication stress as a target, in addition to the challenges stress in the clinic. Introduction mental. In this review, we provide a summary of the therapies centered on enhancing both endogenous and drug-induced rep- The DNA replication machinery successfully carries out accu- lication stress and discuss the rationales associated with them. We rate genome duplication in the face of numerous obstacles, many also highlight the potential of using replication stress to stimulate of which cause DNA replication stress.
    [Show full text]
  • Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer
    cells Article Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer 1, 1, 1 1 Felix Meyer y, Saskia Becker y, Sandra Classen , Ann Christin Parplys , Wael Yassin Mansour 1,2, Britta Riepen 1, Sara Timm 3, Claudia Ruebe 3 , Maria Jasin 4, Harriet Wikman 5 , Cordula Petersen 6, Kai Rothkamm 1 and Kerstin Borgmann 1,* 1 Laboratory of Radiobiology and Experimental Radiooncology, Center of Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] (F.M.); [email protected] (S.B.); [email protected] (S.C.); [email protected] (A.C.P.); [email protected] (W.Y.M.); [email protected] (B.R.); [email protected] (K.R.) 2 Tumor Biology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt 3 Department of Radiation Oncology, Saarland University, 66421 Hamburg/Saar, Germany; [email protected] (S.T.); [email protected] (C.R.) 4 Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; [email protected] 5 Department of Tumor Biology, University Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] 6 Department of Radiotherapy and Radiooncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-40-74105-3596 These authors contributed equally to the manuscript. y Received: 10 December 2019; Accepted: 14 January 2020; Published: 17 January 2020 Abstract: Chromosomal instability not only has a negative effect on survival in triple-negative breast cancer, but also on the well treatable subgroup of luminal A tumors.
    [Show full text]
  • A Pan-Cancer Transcriptome Analysis Identifies Replication Fork and Innate Immunity Genes As Modifiers of Response to the CHK1 Inhibitor Prexasertib
    www.oncotarget.com Oncotarget, 2020, Vol. 11, (No. 3), pp: 216-236 Research Paper A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Wayne D. Blosser1, Jack A. Dempsey1, Ann M. McNulty1, Xi Rao1, Philip J. Ebert1, Caitlin D. Lowery1, Philip W. Iversen1, Yue Wang Webster1, Gregory P. Donoho1, Xueqian Gong1, Farhana F. Merzoug1, Sean Buchanan1, Karsten Boehnke2, Chunping Yu3, Xin Tian You3, Richard P. Beckmann1, Wenjuan Wu1, Samuel C. McNeely1, Aimee Bence Lin1 and Ricardo Martinez1 1Eli Lilly and Company, Indianapolis, IN, USA 2Eli Lilly and Company, New York, NY, USA 3Eli Lilly and Company, Shanghai, China Correspondence to: Ricardo Martinez, email: [email protected] Keywords: CHK1; prexasertib; replication stress; replication fork; innate immunity Received: September 19, 2019 Accepted: December 02, 2019 Published: January 21, 2020 Copyright: Blosser et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT The combined influence of oncogenic drivers, genomic instability, and/or DNA damage repair deficiencies increases replication stress in cancer. Cells with high replication stress rely on the upregulation of checkpoints like those governed by CHK1 for survival. Previous studies of the CHK1 inhibitor prexasertib demonstrated activity across multiple cancer types. Therefore, we sought to (1) identify markers of prexasertib sensitivity and (2) define the molecular mechanism(s) of intrinsic and acquired resistance using preclinical models representing multiple tumor types.
    [Show full text]
  • 2018 Journal Citation Reports Journals in the 2018 Release of JCR 2 Journals in the 2018 Release of JCR
    2018 Journal Citation Reports Journals in the 2018 release of JCR 2 Journals in the 2018 release of JCR Abbreviated Title Full Title Country/Region SCIE SSCI 2D MATER 2D MATERIALS England ✓ 3 BIOTECH 3 BIOTECH Germany ✓ 3D PRINT ADDIT MANUF 3D PRINTING AND ADDITIVE MANUFACTURING United States ✓ 4OR-A QUARTERLY JOURNAL OF 4OR-Q J OPER RES OPERATIONS RESEARCH Germany ✓ AAPG BULL AAPG BULLETIN United States ✓ AAPS J AAPS JOURNAL United States ✓ AAPS PHARMSCITECH AAPS PHARMSCITECH United States ✓ AATCC J RES AATCC JOURNAL OF RESEARCH United States ✓ AATCC REV AATCC REVIEW United States ✓ ABACUS-A JOURNAL OF ACCOUNTING ABACUS FINANCE AND BUSINESS STUDIES Australia ✓ ABDOM IMAGING ABDOMINAL IMAGING United States ✓ ABDOM RADIOL ABDOMINAL RADIOLOGY United States ✓ ABHANDLUNGEN AUS DEM MATHEMATISCHEN ABH MATH SEM HAMBURG SEMINAR DER UNIVERSITAT HAMBURG Germany ✓ ACADEMIA-REVISTA LATINOAMERICANA ACAD-REV LATINOAM AD DE ADMINISTRACION Colombia ✓ ACAD EMERG MED ACADEMIC EMERGENCY MEDICINE United States ✓ ACAD MED ACADEMIC MEDICINE United States ✓ ACAD PEDIATR ACADEMIC PEDIATRICS United States ✓ ACAD PSYCHIATR ACADEMIC PSYCHIATRY United States ✓ ACAD RADIOL ACADEMIC RADIOLOGY United States ✓ ACAD MANAG ANN ACADEMY OF MANAGEMENT ANNALS United States ✓ ACAD MANAGE J ACADEMY OF MANAGEMENT JOURNAL United States ✓ ACAD MANAG LEARN EDU ACADEMY OF MANAGEMENT LEARNING & EDUCATION United States ✓ ACAD MANAGE PERSPECT ACADEMY OF MANAGEMENT PERSPECTIVES United States ✓ ACAD MANAGE REV ACADEMY OF MANAGEMENT REVIEW United States ✓ ACAROLOGIA ACAROLOGIA France ✓
    [Show full text]